(via TheNewswire)

Denver, Colorado - TheNewswire - January 29, 2020 - CBD Global Sciences Inc. ( CSE:CBDN) (CNSX:CBDN.CN) (Frankfurt:GS3), ("CBD Global" or the "Company" ), and our cannabidiol (CBD) brand "Aethics", are excited to announce a partnership with one of the largest and most recognizable travel retailers in North America.

As of today, the entire Aethics topical line is offered for sale in well over 100 of our newest partner's nearly 1,000 travel-based locations, including airports and train stations, with additional Aethics product lines expected to be available in-store soon. This marks a significant opportunity for CBD Global to expand the retail availability of our high-quality, full-spectrum CBD products to consumers.

Brad Wyatt, CEO of CBD Global, stated " CBD Global is honored to be working with such a reputable and recognizable group. As the leader and trendsetter in travel retail, they represent everything we look for in a retail partner. We have been impressed with their deep understanding of CBD and we think their dynamic vision for its future in travel retail is something everyone should be excited about."

Keep an eye on our upcoming press releases for a joint announcement from CBD Global and our newest major retail partner!

ABOUT CBD GLOBAL SCIENCES INC.

CBD Global Sciences Inc., is a vertically integrated hemp-based CBD producer, extractor, and branding investment vehicle which currently owns two product categories, branded under the name AETHICS ( www.aethics.com ) and CANNAOIL ( www.cannaoilshop.com ), which include CBD Oil tinctures (liquid products), CBD capsules, CBD topicals and CBD hydration products. CBD Global Sciences hemp-derived CBD extracts are sold through select distributors, brick and mortar retailers, and online.

CBD Global Sciences, through its wholly owned subsidiary, Strasburg Pharms, grows and operates irrigated land in Colorado, that grows hemp with only all-natural Colorado water, soil, sun and nutrients and NEVER sprayed with pesticides or chemicals. Our genetics are hand selected and maintained to present the best cannabinoid profile with extremely high CBD. The extraction/processing facility, operated by CBD Global Sciences, is located approximately 40 minutes from the farm.

For further information, please contact Bruce Nurse, Investor Relations, (888) 401-2239, info@cbdglobalsciences.com

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAS REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION: This news release includes certain "forward-looking statements" under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to future developments and the business and operations of the Corporation after the CSE listing. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to general business, economic, competitive, political and social uncertainties; and delay or failure to receive board, shareholder or regulatory approvals. Readers should not place undue reliance on forward-looking statements. The Corporation disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

NOT FOR DISTRIBUTION OR DISSEMINATION INTO THE UNITED STATES

Copyright (c) 2020 TheNewswire - All rights reserved.